These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

65 related items for PubMed ID: 2855242

  • 1. Regulation of adenylate cyclase by chronic exposure to cannabimimetic drugs.
    Dill JA, Howlett AC.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):1157-63. PubMed ID: 2855242
    [Abstract] [Full Text] [Related]

  • 2. Involvement of Gi in the inhibition of adenylate cyclase by cannabimimetic drugs.
    Howlett AC, Qualy JM, Khachatrian LL.
    Mol Pharmacol; 1986 Mar; 29(3):307-13. PubMed ID: 2869405
    [Abstract] [Full Text] [Related]

  • 3. Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes.
    Howlett AC.
    Mol Pharmacol; 1985 Apr; 27(4):429-36. PubMed ID: 2984538
    [Abstract] [Full Text] [Related]

  • 4. Cannabinoid inhibition of adenylate cyclase. Pharmacology of the response in neuroblastoma cell membranes.
    Howlett AC, Fleming RM.
    Mol Pharmacol; 1984 Nov; 26(3):532-8. PubMed ID: 6092901
    [Abstract] [Full Text] [Related]

  • 5. Properties of delta opioid receptor in neuroblastoma NS20Y: receptor activation and neuroblastoma proliferation.
    Law PY, Bergsbaken C.
    J Pharmacol Exp Ther; 1995 Jan; 272(1):322-32. PubMed ID: 7815347
    [Abstract] [Full Text] [Related]

  • 6. Effects of delta 1-tetrahydrocannabinol on cyclic AMP in cultured human diploid fibroblasts.
    Kelly LA, Butcher RW.
    J Cyclic Nucleotide Res; 1979 Jan; 5(4):303-13. PubMed ID: 91629
    [Abstract] [Full Text] [Related]

  • 7. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR, Lee M, Condie RB, Pulaski JT, Kaminski NE.
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [Abstract] [Full Text] [Related]

  • 8. An assessment of the role of opioid receptors in the response to cannabimimetic drugs.
    Devane WA, Spain JW, Coscia CJ, Howlett AC.
    J Neurochem; 1986 Jun; 46(6):1929-35. PubMed ID: 3009717
    [Abstract] [Full Text] [Related]

  • 9. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells.
    Prather PL, Tsai AW, Law PY.
    J Pharmacol Exp Ther; 1994 Jul; 270(1):177-84. PubMed ID: 8035314
    [Abstract] [Full Text] [Related]

  • 10. Cellular effects of cannabinoids.
    Martin BR.
    Pharmacol Rev; 1986 Mar; 38(1):45-74. PubMed ID: 2872689
    [Abstract] [Full Text] [Related]

  • 11. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor- kappa B/Rel activation.
    Jeon YJ, Yang KH, Pulaski JT, Kaminski NE.
    Mol Pharmacol; 1996 Aug; 50(2):334-41. PubMed ID: 8700141
    [Abstract] [Full Text] [Related]

  • 12. Specific inhibition of FSH-stimulated cAMP accumulation by delta 9-tetrahydrocannabinol in cultured rat granulosa cells.
    Treinen KA, Sneeden JL, Heindel JJ.
    Toxicol Appl Pharmacol; 1993 Jan; 118(1):53-7. PubMed ID: 8381567
    [Abstract] [Full Text] [Related]

  • 13. Enkephalin inhibition of adenylate cyclase activity in neuroblastoma N18TG2 cells: effect of sulfatide incorporation.
    Law PY, Nicksic TD, Loh HH.
    Adv Biochem Psychopharmacol; 1980 Jan; 22():291-304. PubMed ID: 6249077
    [Abstract] [Full Text] [Related]

  • 14. Forskolin potentiation of cholera toxin-stimulated cyclic AMP accumulation in intact C6-2B cells. Evidence for enhanced Gs-C coupling.
    Barovsky K, Brooker G.
    Mol Pharmacol; 1985 Dec; 28(6):502-7. PubMed ID: 3001496
    [Abstract] [Full Text] [Related]

  • 15. Structure-activity relationships for cannabinoid receptor-binding and analgesic activity: studies of bicyclic cannabinoid analogs.
    Melvin LS, Milne GM, Johnson MR, Subramaniam B, Wilken GH, Howlett AC.
    Mol Pharmacol; 1993 Nov; 44(5):1008-15. PubMed ID: 8246904
    [Abstract] [Full Text] [Related]

  • 16. Neurotensin-mediated inhibition of cyclic AMP formation in neuroblastoma N1E115 cells: involvement of the inhibitory GTP-binding component of adenylate cyclase.
    Bozou JC, Amar S, Vincent JP, Kitabgi P.
    Mol Pharmacol; 1986 May; 29(5):489-96. PubMed ID: 3010077
    [Abstract] [Full Text] [Related]

  • 17. Involvement of protein kinase C in the UTP-mediated potentiation of cyclic AMP accumulation in mouse J774 macrophages.
    Lin WW, Chen BC.
    Br J Pharmacol; 1997 Aug; 121(8):1749-57. PubMed ID: 9283713
    [Abstract] [Full Text] [Related]

  • 18. Effects of clozapine on rat striatal muscarinic receptors coupled to inhibition of adenylyl cyclase activity and on the human cloned m4 receptor.
    Olianas MC, Maullu C, Onali P.
    Br J Pharmacol; 1997 Oct; 122(3):401-8. PubMed ID: 9351494
    [Abstract] [Full Text] [Related]

  • 19. The D2S and D2L dopamine receptor isoforms are differentially regulated in Chinese hamster ovary cells.
    Zhang LJ, Lachowicz JE, Sibley DR.
    Mol Pharmacol; 1994 May; 45(5):878-89. PubMed ID: 7910658
    [Abstract] [Full Text] [Related]

  • 20. Desensitization in rat parotid to beta-adrenergic agonists and counteracting effects of forskolin are conserved in membrane and detergent-solubilized adenylate cyclase catalyst activity.
    Harper JF.
    J Cyclic Nucleotide Protein Phosphor Res; 1986 May; 11(3):167-76. PubMed ID: 2876014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.